Skip directly to content

Innovation in the UK

Part of our Research and Development (R&D) facility in Sandwich, Kent.

 

Pfizer has a long and proud history of being part of world class science in the UK. Our site in Sandwich, Kent was one of the world’s first mass production facilities for penicillin back in the 1950’s and continues to be an important location for Pfizer over 65 years later. During the last 20 years, our scientists in Sandwich have discovered new treatments for important disease areas and disorders including heart disease, HIV and migraine.

 

In addition to our research and development (R&D) centre in Sandwich, and Devices Centre of Excellence (DCoE) in Cambridge, we also invest time, knowledge and money, working alongside British science. During 2018 we were involved in 104 research and development collaborations and alliances working with scientists, academics and clinicians throughout the UK.1

 

Between 2014 - 2018 we spent more than £1.22billion supporting UK research and development to develop the medicines and vaccines of the future.2

The thriving Discovery Park site in Sandwich, has attracted many smaller biotech companies and start-ups, and continues to play an important role in developing Pfizer’s future pipeline. At the site, our Material Sciences, Pharmaceutical Sciences Small Molecule team use their specialist expertise to turn experimental compounds into liquid and solid dose medicines.

 

What’s more, Sandwich is home to Pfizer’s fully automated 'Pilot Plant' that manufactures medicines for use in Pfizer’s clinical trials worldwide, as well as our Global Regulatory Affairs Team, Quality Assurance Team, Material Characterisation TeamAnti-Counterfeit Laboratory and many business support functions.

 

References

  1. Pfizer UK data on file. August 2019.
  2. Pfizer UK data on file. December 2019.
PP-PFE-GBR-2177 / Dec 2019